Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$65.54 USD

65.54
6,458,814

+1.96 (3.08%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $65.43 -0.11 (-0.17%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (94 out of 244)

Industry: Medical Services

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Zacks Equity Research

CVS Health (CVS) Gains As Market Dips: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $62.99, marking a +0.08% move from the previous day.

Zacks Equity Research

Is CVS Health (CVS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why You Should Add Stryker (SYK) to Your Portfolio Now

Stryker's (SYK) core Mako Platform has been consistently driving its top line.

Zacks Equity Research

Easy Investing Secrets to an Early Retirement - October 09, 2019

Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.

Zacks Equity Research

Walgreens Inks Retail Health Collaboration Deal With Novant

This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.

Zacks Equity Research

CVS Health (CVS) Stock Moves -0.4%: What You Should Know

CVS Health (CVS) closed the most recent trading day at $61.99, moving -0.4% from the previous trading session.

Zacks Equity Research

Signs That Your Trading Will Ruin Your Retirement - October 07, 2019

Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.

Zacks Equity Research

Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sapna Bagaria headshot

Health Insurers Hope to Gain From Executive Order on Medicare

President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.

Zacks Equity Research

LabCorp to Expand Hematology Suite With Sysmex America Deal

LabCorp (LH) will get to use Sysmex' advanced XN-9100 system, which is a scalable, modular automation system.

Christopher Vargas headshot

Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales

Walgreens (WBA) announced today that they would be suspending the sales of Sanofi's (SNY) heartburn medication Zantac.

Zacks Equity Research

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $63.07, moving +1.59% from the previous trading session.

Zacks Equity Research

Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View

Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.

Zacks Equity Research

Are Investors Undervaluing CVS Health (CVS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sreyoshi Mukherjee headshot

Opioid Overdose Crisis in US Likely to Affect These 3 Stocks

Increasing lawsuits against pharmaceutical companies are likely to impact retailers and distributors.

Urmimala Biswas headshot

Pharmacies & Drug Stores Industry Boasts Bright Prospects

The Retail - Pharmacies and Drug Stores industry witnesses heavy consolidation.

Zacks Equity Research

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $63.35, marking a -1.48% move from the previous day.

Zacks Equity Research

Cigna Expands Health Care Exchange Offerings to New Markets

Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.

Zacks Equity Research

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.

Zacks Equity Research

Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy

Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy

Zacks Equity Research

Here's How Cigna (CI) is Poised Amid Political Uncertainty

Growth in health services, government business and international markets drive Cigna's (CI) stock.

Maharathi Basu headshot

5 Stocks in the Limelight After Recent Broker Rating Upgrade

Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for September 16th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 16th

Sweta Killa headshot

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP